To further assess and quantify the extent of pTDP-43 pathology as well as AD associated neuropathological changes including phosphorylated Tau and Aβ-42 pathology, we performed meso-scale discovery (MSD) immunoassays on hippocampal tissue lysates (Fig. 1b-d; Supplementary Table 3). This evidence concerns the gene MAPT and Alzheimer disease.